Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFNfreeCOG: Neuropsychiatric effects of IFN-free HCV therapy
NCT02469012Unknown
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label trial of sofosbuvir, daclatasvir, ledipasvir and ribavirin in hepatitis C (HCV). Status: unknown.
02
Drugs
sofosbuvirdaclatasvirledipasvirribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02469012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469012.